 OSAKA, Japan CAMBRIDGE, Mass.-- BUSINESS WIRE -- Takeda TSE:4502NYSE:TAK today announced that it will present 15 company-sponsored abstracts at the 64th American Society of Hematology ASH Annual Meeting being held December 10-13, 2022 in New Orleans. Takedas latest research focuses on improving long-term outcomes for patients with hematologic diseases. 